tiprankstipranks
Trending News
More News >
Neuren Pharmaceuticals Limited (NURPF)
:NURPF
US Market

Neuren Pharmaceuticals Limited (NURPF) Ratios

Compare
52 Followers

Neuren Pharmaceuticals Limited Ratios

NURPF's free cash flow for Q4 2024 was AU$0.92. For the 2024 fiscal year, NURPF's free cash flow was decreased by AU$ and operating cash flow was AU$0.91. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
25.77 5.78 25.77 49.87 33.12
Quick Ratio
25.77 5.78 25.77 49.87 34.13
Cash Ratio
23.95 0.40 23.95 45.81 32.12
Solvency Ratio
0.12 3.67 0.12 -9.70 -12.20
Operating Cash Flow Ratio
2.14 4.32 2.14 -12.42 -10.73
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
AU$ 41.57MAU$ 204.39MAU$ 41.57MAU$ 39.24MAU$ 24.19M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.04 1.21 1.04 1.02 1.03
Debt Service Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
25.33 -0.09 25.33 4.47 2.75
Profitability Margins
Gross Profit Margin
99.93%88.47%99.93%99.75%99.16%
EBIT Margin
-11.04%85.89%-11.04%-343.79%-1382.15%
EBITDA Margin
-10.90%85.92%-10.90%-257.27%-1227.75%
Operating Profit Margin
-10.97%74.37%-10.97%-357.52%-1328.59%
Pretax Profit Margin
-4.67%88.45%-4.67%-343.79%-1382.15%
Net Profit Margin
1.26%67.73%1.26%-243.79%-1282.15%
Continuous Operations Profit Margin
1.26%67.73%1.26%-243.79%-1282.15%
Net Income Per EBT
-27.06%76.57%-27.06%70.91%92.76%
EBT Per EBIT
42.61%118.93%42.61%96.16%104.03%
Return on Assets (ROA)
0.43%63.35%0.43%-19.46%-36.84%
Return on Equity (ROE)
0.44%76.55%0.44%-19.86%-37.99%
Return on Capital Employed (ROCE)
-3.84%84.06%-3.84%-29.12%-39.36%
Return on Invested Capital (ROIC)
1.04%64.37%1.04%-20.65%-36.52%
Return on Tangible Assets
0.43%63.35%0.43%-19.46%-36.84%
Earnings Yield
0.02%4.98%0.02%-1.76%-6.66%
Efficiency Ratios
Receivables Turnover
13.36 16.09 13.36 2.25 0.95
Payables Turnover
0.04 39.63 0.04 0.03 0.04
Inventory Turnover
0.00 0.00 0.00 8.00K >-0.01
Fixed Asset Turnover
693.00 5.39K 693.00 266.42 71.70
Asset Turnover
0.34 0.94 0.34 0.08 0.03
Working Capital Turnover Ratio
0.36 1.89 0.36 0.10 0.04
Cash Conversion Cycle
-9.39K 13.47 -9.39K -11.02K -55.70K
Days of Sales Outstanding
27.31 22.68 27.31 162.58 384.34
Days of Inventory Outstanding
0.00 0.00 0.00 0.05 -45.93K
Days of Payables Outstanding
9.42K 9.21 9.42K 11.18K 10.16K
Operating Cycle
27.31 22.68 27.31 162.62 -45.54K
Cash Flow Ratios
Operating Cash Flow Per Share
0.03 1.46 0.03 -0.08 -0.08
Free Cash Flow Per Share
0.03 1.45 0.03 -0.08 -0.08
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.99 1.00 0.99 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
189.42 4.62K 189.42 -997.00 -1.35K
Capital Expenditure Coverage Ratio
189.42 4.62K 189.42 -997.00 -1.35K
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.25 0.80 0.25 -3.12 -11.27
Free Cash Flow Yield
0.36%5.86%0.36%-2.25%-5.85%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
5.44K 20.08 5.44K -56.97 -15.02
Price-to-Sales (P/S) Ratio
68.81 13.60 68.81 138.88 192.61
Price-to-Book (P/B) Ratio
24.08 15.37 24.08 11.31 5.71
Price-to-Free Cash Flow (P/FCF) Ratio
279.73 17.06 279.73 -44.49 -17.08
Price-to-Operating Cash Flow Ratio
278.25 17.05 278.25 -44.53 -17.10
Price-to-Earnings Growth (PEG) Ratio
-53.22 <0.01 -53.22 2.48 0.69
Price-to-Fair Value
24.08 15.37 24.08 11.31 5.71
Enterprise Value Multiple
-606.08 15.74 -606.08 -49.51 -12.94
Enterprise Value
961.25M 3.14B 961.25M 407.21M 113.92M
EV to EBITDA
-606.08 15.74 -606.08 -49.51 -12.94
EV to Sales
66.05 13.52 66.05 127.37 158.88
EV to Free Cash Flow
268.50 16.97 268.50 -40.80 -14.09
EV to Operating Cash Flow
267.09 16.96 267.09 -40.84 -14.10
Tangible Book Value Per Share
0.33 1.61 0.33 0.33 0.23
Shareholders’ Equity Per Share
0.33 1.61 0.33 0.33 0.23
Tax and Other Ratios
Effective Tax Rate
1.27 0.23 1.27 0.29 0.07
Revenue Per Share
0.12 1.83 0.12 0.03 <0.01
Net Income Per Share
<0.01 1.24 <0.01 -0.07 -0.09
Tax Burden
-0.27 0.77 -0.27 0.71 0.93
Interest Burden
0.42 1.03 0.42 1.00 1.00
Research & Development to Revenue
0.87 0.12 0.87 2.98 10.83
SG&A to Revenue
0.24 0.03 0.24 0.60 2.46
Stock-Based Compensation to Revenue
0.14 0.00 0.14 0.26 0.55
Income Quality
19.56 1.18 19.56 1.28 0.88
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis